| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fbcdb105756f552ddf2e9ae2cfcf40a |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3284c12b3420ecc0b790cf7bc13ec667
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0496d9a675750c888877ea28ab34637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006aaef3e0789a6d4307dcf62d236265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30c3d322d448188cd6ffb2c16e56bd8c |
| publicationDate |
2019-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2019156817-A |
| titleOfInvention |
Therapeutic drug through regulation of Wnt / β-catenin signal activation by R-spondin-2 |
| abstract |
An object of the present invention is to provide an effective therapeutic means for a disease caused by or accompanied by an abnormality in activation of Wnt / β-catenin signal. A therapeutic agent containing mianserin or a pharmaceutically acceptable salt thereof as an active ingredient is provided. The therapeutic agent of the present invention is applied to the treatment of osteoarthritis, for example. [Selection figure] None |
| priorityDate |
2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |